Literature DB >> 10391896

Inactivation of the inhibitory kappaB protein kinase/nuclear factor kappaB pathway by Par-4 expression potentiates tumor necrosis factor alpha-induced apoptosis.

M T Diaz-Meco1, M J Lallena, A Monjas, S Frutos, J Moscat.   

Abstract

Par-4 is a novel protein identified in cells undergoing apoptosis. The ability of Par-4 to promote apoptotic cell death is dependent on the binding and inactivation of the atypical protein kinases C (PKCs). This subfamily of kinases has been reported to control nuclear factor kappaB (NF-kappaB) through the regulation of the IkappaB kinase activity. NF-kappaB activation by tumor necrosis factor alpha (TNFalpha) provides a survival signal that impairs the TNFalpha-induced apoptotic response. We show here that expression of Par-4 inhibits the TNFalpha-induced nuclear translocation of p65 as well as the kappaB-dependent promoter activity. Interestingly, Par-4 expression blocks inhibitory kappaB protein (IkappaB) kinase activity, which leads to the inhibition of IkappaB phosphorylation and degradation, in a manner that is dependent on its ability to inhibit lambda/iotaPKC. Of potential functional relevance, the expression of Par-4 allows TNFalpha to induce apoptosis in NIH-3T3 cells. In addition, the down-regulation of Par-4 levels by oncogenic Ras sensitizes cells to TNFalpha-induced NF-kappaB activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391896     DOI: 10.1074/jbc.274.28.19606

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  MEK5, a new target of the atypical protein kinase C isoforms in mitogenic signaling.

Authors:  M T Diaz-Meco; J Moscat
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 2.  The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters.

Authors:  J Moscat; M T Diaz-Meco
Journal:  EMBO Rep       Date:  2000-11       Impact factor: 8.807

3.  pH-induced folding of an apoptotic coiled coil.

Authors:  K Dutta; A Alexandrov; H Huang; S M Pascal
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

4.  NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy.

Authors:  Raquel Gómez-Sintes; José J Lucas
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

Review 5.  Cancer-selective apoptotic effects of extracellular and intracellular Par-4.

Authors:  T Shrestha-Bhattarai; V M Rangnekar
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

6.  Prostate apoptosis response-4 is expressed in normal cholangiocytes, is down-regulated in human cholangiocarcinoma, and promotes apoptosis of neoplastic cholangiocytes when induced pharmacologically.

Authors:  Antonio Franchitto; Alessia Torrice; Rossella Semeraro; Cristina Napoli; Gennaro Nuzzo; Felice Giuliante; Gianfranco Alpini; Guido Carpino; Pasquale Bartolomeo Berloco; Luciano Izzo; Antonio Bolognese; Paolo Onori; Anastasia Renzi; Alfredo Cantafora; Eugenio Gaudio; Domenico Alvaro
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

7.  Par-4 binds to topoisomerase 1 and attenuates its DNA relaxation activity.

Authors:  Anindya Goswami; Shirley Qiu; Thomas S Dexheimer; Padhma Ranganathan; Ravshan Burikhanov; Yves Pommier; Vivek M Rangnekar
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

8.  Regulation of mature T lymphocyte proliferation and differentiation by Par-4.

Authors:  María José Lafuente; Pilar Martin; Isabel Garcia-Cao; María Teresa Diaz-Meco; Manuel Serrano; Jorge Moscat
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

9.  Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network.

Authors:  Bi-Dar Wang; Christina Leah B Kline; Danielle M Pastor; Thomas L Olson; Bryan Frank; Truong Luu; Arun K Sharma; Gavin Robertson; Matthew T Weirauch; Steven R Patierno; Joshua M Stuart; Rosalyn B Irby; Norman H Lee
Journal:  Mol Cancer       Date:  2010-04-30       Impact factor: 27.401

10.  Fbxo45-mediated degradation of the tumor-suppressor Par-4 regulates cancer cell survival.

Authors:  X Chen; A A Sahasrabuddhe; P Szankasi; F Chung; V Basrur; V M Rangnekar; M Pagano; M S Lim; K S J Elenitoba-Johnson
Journal:  Cell Death Differ       Date:  2014-07-04       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.